P-012 XPD polymorphism in second-line treatment with...

Lung Cancer 2005 / 7 Vol. 49

P-012 XPD polymorphism in second-line treatment with gemcitabine or innotecan in advanced non-small cell lung cancer (NCSLC) patients

Camps, C., Alonso, G., de las Peñas, R., Provencio, M., Terrasa, J., Lopez-Vivanco, G., Artal, A., Garcia-Gomez, R., Pujol, E., Rosell, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80506-9
Date:
July, 2005
File:
PDF, 184 KB
english, 2005
Conversion to is in progress
Conversion to is failed